ソマトスタチン受容体アンタゴニスト化合物及びその使用方法

Title:

ソマトスタチン受容体アンタゴニスト化合物及びその使用方法

Document Type and Number:

Japanese Patent JP6989529

Kind Code:

B2

Abstract:

The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I:compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.

More Like This:

JPH09510086	[Title of the Invention] Mosaic polypeptides and methods for detecting hepatitis E virus.
WO/1997/027276	NUCLEIC ACIDS ENCODING POLYPEPTIDES HAVING ABSIDIA LIPASE ACTIVITY
JP2018064573	METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS, AND COMPOSITIONS CONTAINING THE SAME

Inventors:

Arnes Stefan Paul
Jacquis James Brian
Bow Delet Davey Jeremy
Simonson Eric Roy
Riggins Richard Tom
Kumar Nag Shawan
Shet Tom Han Xiao

Application Number:

JP2018560701A

Publication Date:

January 05, 2022

Filing Date:

February 09, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CRD Ventures Inc.

International Classes:

C07K7/06; A61K38/08; A61P3/10; A61P43/00

Domestic Patent References:

JP2011520787A
JP2010506943A

Other References:

DIABETES,2013年,vol.62,p.2968-2977

Attorney, Agent or Firm:

Hayashi Ichiyoshi
Tetsuo Shiba
Takuya Saito
Iwaike Mitsuru
Kazuhiro Kosuga
Hiroshi Hayashi

Previous Patent: Mutant 3-hydroxybutyrate dehydrogenase from Rhodobacter sphaeroides and methods containing it

Next Patent: Electromechanical locking latch